Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 736 to 750 of 1108 results for infections

  1. WoundExpress to manage lower leg wounds (MIB261)

    NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .

    Medtech innovation briefing
    Published
    1 June 2021

  2. Referral criteria for the foot protection service and the multidisciplinary foot care service:- When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    monitor and evaluate the rates (and recurrent rates) of foot ulceration, infection and gangrene resulting from diabetes, resource use...

    Research recommendation
    Published
    12 October 2015

  3. Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a transjugular intrahepatic portosystemic shunt (TIPS)?

    following TIPS (for example, hepatic encephalopathy, shunt blockages, infection and cardiac problems) have on each person. It is...

    Research recommendation
    Published
    11 January 2024

  4. Interventions to improve the acceptability and uptake of HIV testing among people at higher risk:- What interventions would be effective and cost effective among people at higher risk in the UK to increase uptake of HIV testing among people who may have undiagnosed HIV?

    increasing the uptake of HIV testing will reduce the pool of undiagnosed infection, improve outcomes for those affected (because of...

    Research recommendation
    Published
    14 February 2017

  5. ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions (MIB295)

    NICE has developed a medtech innovation briefing (MIB) on ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions .

    Medtech innovation briefing
    Published
    10 May 2022

  6. Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)

    Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    23 November 2016
    View recommendations

    Sections for TA418

  7. Trabectedin for the treatment of advanced soft tissue sarcoma (TA185)

    Evidence-based recommendations on trabectedin (Yondelis) for treating advanced soft tissue sarcoma in adults.

    Technology appraisal guidance
    Last updated
    8 February 2021
    View recommendations

    Sections for TA185

  8. Faecal microbiota transplant for recurrent Clostridioides difficile infection (MTG71)

    We have moved Medical technologies guidance 71 to become HealthTech guidance 638. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. Faecal microbiota transplant for recurrent Clostridium difficile infection (IPG485)

    We have moved interventional procedures guidance 485 to become HealthTech guidance 338. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)

    This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks.

    NICE guideline
    Published
    27 November 2024
    View recommendations

    Sections for NG245

  11. Debridement:- What is the effect of enzymatic debridement of non-viable tissue compared with sharp debridement on the rate of healing of pressure ulcers in adults?

    of dead tissue is vital as its presence can delay healing and encourage infection. Although autolytic debridement via natural processes...

    Research recommendation
    Published
    9 June 2015

  12. Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the community predict neutropenic sepsis and the outcomes of these episodes.

    Referral criteria that are too narrow will delay the emergency treatment of infection and may lead to death, increased need for...

    Research recommendation
    Published
    9 June 2015

  13. Long‑term consequences of planning birth in different settings: What are the long‑term consequences for women and babies of planning birth in different settings?

    long‑term physical morbidity, pain after birth, readmission to hospital, infection, psychological morbidity (for example, postnatal...

    Research recommendation
    Published
    6 January 2023

  14. Sipavibart for preventing COVID-19 [ID6282]

    In development Reference number: GID-TA11352 Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Low back pain and sciatica in over 16s (QS155)

    This quality standard covers the assessment and management of non-specific low back pain and sciatica in young people and adults aged 16 years and over. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    27 July 2017
    View quality statements

    Sections for QS155